Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells (Q39166807)

9 September 2017

Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells (English)

1 reference

9 September 2017

0 references

1 reference

M-H Wu

1

1 reference

9 September 2017

C-Y Huang

2

1 reference

9 September 2017

J-A Lin

3

1 reference

9 September 2017

S-W Wang

4

1 reference

9 September 2017

C-Y Peng

5

1 reference

9 September 2017

H-C Cheng

6

1 reference

9 September 2017

C-H Tang

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

15 April 2013

1 reference

9 September 2017

1 reference

9 September 2017

33

1 reference

9 September 2017

13

1 reference

9 September 2017

1725-1735

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.109

9 September 2017

0 references

cites work

Cancer prevention by targeting angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Tumor angiogenesis: molecular pathways and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Dual role of macrophages in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Expression of endothelin 1 and its angiogenic role in meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

VEGF-A and the induction of pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Antiangiogenic agents and endothelin antagonists in advanced castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Emerging role of endothelin-1 in tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Cellular repressor of E1A-stimulated genes regulates vascular endothelial cell migration by the ILK/AKT/mTOR/VEGF(165) signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Damage formation and repair efficiency in the p53 gene of cell lines and blood lymphocytes assayed by multiplex long quantitative polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Ultrasound induces hypoxia-inducible factor-1 activation and inducible nitric-oxide synthase expression through the integrin/integrin-linked kinase/Akt/mammalian target of rapamycin pathway in osteoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Chemotherapy and P-glycoprotein expression in chondrosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Anti-VEGF Treatment of Corneal Neovascularization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Inhibiteurs du récepteur A de l’endothéline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.109

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.109

1 reference

Dimensions Publication ID

9 September 2017

0 references

1 reference